Tachykinins and tachykinin receptors: a growing family

被引:379
作者
Pennefather, JN
Lecci, A
Candenas, ML
Patak, E
Pinto, FM
Maggi, CA
机构
[1] Ctr Invest Cientificas Isla La Cartuja, Inst Invest Quim, Seville 41092, Spain
[2] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut Biol & Pharmacol, Parkville, Vic 3052, Australia
[3] Menarini Ric SpA Res Labs, Dept Pharmacol, I-50131 Florence, Italy
[4] Royal Hosp Women, Dept Anaesthet, Carlton, Vic 3053, Australia
关键词
tachykinins; tachykinin receptors; substance P; neurokinin A; neurokinin B; endokinins A; B; C; D;
D O I
10.1016/j.lfs.2003.09.039
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The peptides of the tachykinin family are widely distributed within the mammalian peripheral and central nervous systems and play a well-recognized role as excitatory neurotransmitters. Currently, the concept that tachykinins act exclusively as neuropeptides is being challenged, since the best known members of the family, substance P, neurokinin A and neurokinin B, are also present in non-neuronal cells and in non-innervated tissues. Moreover, the recently cloned mammalian tachykinins hemokinin-1 and endokinins are primarily expressed in non-neuronal cells, suggesting a widespread distribution and important role for these peptides as intercellular signaling molecules. The biological actions of tachykinins are mediated through three types of receptors denoted NK1, NK2 and NK3 that belong to the family of G protein-coupled receptors. The identification of additional tachykinins. has reopened the debate of whether more tachykinin receptors exist. In this review, we summarize the current knowledge of tachykinins and their receptors. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1445 / 1463
页数:19
相关论文
共 135 条
[71]  
MACDONALD MR, 1988, J BIOL CHEM, V263, P15176
[72]   Principles of tachykininergic co-transmission in the peripheral and enteric nervous system [J].
Maggi, CA .
REGULATORY PEPTIDES, 2000, 93 (1-3) :53-64
[73]   The effects of tachykinins on inflammatory and immune cells [J].
Maggi, CA .
REGULATORY PEPTIDES, 1997, 70 (2-3) :75-90
[74]   The dual nature of the tachykinin NK1 receptor [J].
Maggi, CA ;
Schwartz, TW .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) :351-355
[75]   THE PHARMACOLOGY OF THE EFFERENT FUNCTION OF SENSORY NERVES [J].
MAGGI, CA .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1991, 11 (03) :173-208
[76]   THE MAMMALIAN TACHYKININ RECEPTORS [J].
MAGGI, CA .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1995, 26 (05) :911-944
[77]   THE SENSORY-EFFERENT FUNCTION OF CAPSAICIN-SENSITIVE SENSORY NEURONS [J].
MAGGI, CA ;
MELI, A .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1988, 19 (01) :1-43
[78]   Airway smooth muscle cells express functional neurokinin-1 receptors and the nerve-derived preprotachykinin-A gene - Regulation by passive sensitization [J].
Maghni, K ;
Michoud, MC ;
Alles, M ;
Rubin, A ;
Govindaraju, V ;
Meloche, C ;
Martin, JG .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 28 (01) :103-110
[79]   The psychopharmacology of tachykinin NK-3 receptors in laboratory animals [J].
Massi, M ;
Panocka, I ;
de Caro, G .
PEPTIDES, 2000, 21 (11) :1597-1609
[80]   EVIDENCE FOR A CAPSAICIN-SENSITIVE, TACHYKININ-MEDIATED, COMPONENT IN THE NANC CONTRACTION OF THE RAT URINARY-BLADDER TO NERVE-STIMULATION [J].
MEINI, S ;
MAGGI, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1123-1131